Jiangxi Biotechnology, a leading antiserum platform provider with a full industry chain coverage, continues to lead the industry development – DIR HONGKONG

Hong Kong, May 7, 2025 – (Asia Pacific Business News via SeaPRwire.com) – In the field of biopharmaceuticals, antiserum products, as indispensable biological preparations in clinical emergency and poisoning treatment, have long been in a special position of high barriers and low attention. In this sub-segment, Jiangxi Institute of Biological Products Co., Ltd. ("Jiangxi Biological") has become the leader in the antiserum segment with its profoun…